These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 26522655)
21. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Desjardins L; Liabeuf S; Renard C; Lenglet A; Lemke HD; Choukroun G; Drueke TB; Massy ZA; Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743 [TBL] [Abstract][Full Text] [Related]
22. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202 [TBL] [Abstract][Full Text] [Related]
24. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD. Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902 [TBL] [Abstract][Full Text] [Related]
25. Serum sclerostin is an independent predictor of mortality in hemodialysis patients. Gonçalves FL; Elias RM; dos Reis LM; Graciolli FG; Zampieri FG; Oliveira RB; Jorgetti V; Moysés RM BMC Nephrol; 2014 Dec; 15():190. PubMed ID: 25465028 [TBL] [Abstract][Full Text] [Related]
26. Abdominal aorta and pelvic artery calcifications on plain radiographs may predict mortality in chronic kidney disease, hemodialysis and renal transplantation. Disthabanchong S; Vipattawat K; Phakdeekitcharoen B; Kitiyakara C; Sumethkul V Int Urol Nephrol; 2018 Feb; 50(2):355-364. PubMed ID: 29236239 [TBL] [Abstract][Full Text] [Related]
27. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis. El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103 [TBL] [Abstract][Full Text] [Related]
28. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study. Desbiens LC; Sidibé A; Ung RV; Fortier C; Munger M; Wang YP; Bisson SK; Marquis K; Agharazii M; Mac-Way F Osteoporos Int; 2018 Oct; 29(10):2345-2353. PubMed ID: 29959497 [TBL] [Abstract][Full Text] [Related]
29. Serum fetuin-A levels and abdominal aortic calcification in healthy men - The STRAMBO study. Schoppet M; Rauner M; Benner J; Chapurlat R; Hofbauer LC; Szulc P Bone; 2015 Oct; 79():196-202. PubMed ID: 26079998 [TBL] [Abstract][Full Text] [Related]
31. Growth Arrest-specific 6 Protein and Matrix Gla Protein in Hemodialysis Patients. Hallajzadeh J; Ghorbanihaghjo A; Argani H; Dastmalchi S; Rashtchizadeh N Iran J Kidney Dis; 2015 May; 9(3):249-55. PubMed ID: 25957430 [TBL] [Abstract][Full Text] [Related]
32. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects. Stavrinou E; Sarafidis PA; Koumaras C; Loutradis C; Giamalis P; Tziomalos K; Karagiannis A; Papagianni A Kidney Blood Press Res; 2019; 44(4):679-689. PubMed ID: 31382263 [TBL] [Abstract][Full Text] [Related]
33. Circulating bone-specific alkaline phosphatase and abdominal aortic calcification in maintenance hemodialysis patients. Yan J; Li L; Zhang M; Cai H; Ni Z Biomark Med; 2018 Nov; 12(11):1231-1239. PubMed ID: 30499685 [TBL] [Abstract][Full Text] [Related]
34. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease]. Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189 [TBL] [Abstract][Full Text] [Related]
36. Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Urena Torres P; Friedlander G; de Vernejoul MC; Silve C; Prié D Kidney Int; 2008 Jan; 73(1):102-7. PubMed ID: 17943081 [TBL] [Abstract][Full Text] [Related]
37. Vascular calcification in peritoneal dialysis patients and its association with bone-derived molecules and bone histomorphometry. Pereira L; Mendonça L; Magalhães J; Neto R; Quelhas-Santos J; Oliveira A; Beco A; Frazão J Nefrologia (Engl Ed); 2024; 44(2):224-232. PubMed ID: 37179214 [TBL] [Abstract][Full Text] [Related]
38. Calcification of abdominal aorta in patients recently starting hemodialysis: A single-center experience from Egypt. Fayed A; Elnokeety MM; Attia K; Sharaf El Din UA Saudi J Kidney Dis Transpl; 2019; 30(4):819-824. PubMed ID: 31464238 [TBL] [Abstract][Full Text] [Related]
39. Loss of Residual Renal Function is Associated With Vascular Calcification in Hemodialysis Patients. Chen HC; Chou CY; Jheng JS; Chen IR; Liang CC; Wang SM; Liu JH; Lin SY; Kuo HL; Wang IK; Chang CT; Huang CC Ther Apher Dial; 2016 Feb; 20(1):27-30. PubMed ID: 26637989 [TBL] [Abstract][Full Text] [Related]
40. Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective study. Gifre L; Vidal J; Carrasco JL; Filella X; Ruiz-Gaspà S; Muxi A; Portell E; Monegal A; Guañabens N; Peris P J Bone Miner Res; 2015 Jun; 30(6):1014-21. PubMed ID: 25484108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]